Tracy M.

Tracy M. has a strong background in the field of pharmaceuticals and biosciences. Tracy started their career in 2002 as a Co-op in the Quantitative Expression Group at GlaxoSmithKline. In 2003, they worked as a Co-op in the Gene Interference Group at the same company. In 2004, Tracy had internships at the United States Department of Agriculture, Center for Plant Health Science and Technology, where they worked as a Biological Sciences Technician and later as an Intern in Biotechnology Regulatory Services.

In 2005, Tracy joined the University of North Carolina at Chapel Hill as a Graduate Research Assistant and worked in that role until 2010. Tracy then moved on to Qualyst Transporter Solutions, LLC, where they worked as a Senior Scientist from 2011 to 2013. Tracy's next position was at Cubist Pharmaceuticals, where they held the role of Scientist I from 2014 to 2015.

Tracy then joined Kaleido Biosciences, Inc. in 2016 as a Scientist in Preclinical Pharmacology. Their work at Kaleido Biosciences, Inc. lasted until 2017, when they moved on to Sage Therapeutics. At Sage Therapeutics, they initially worked as a Principal Scientist from 2017 to 2022, and then as a Director of Toxicology starting in December 2022.

Overall, Tracy M. has gained extensive experience and expertise in various roles and organizations within the pharmaceutical and biosciences industry.

Tracy M. pursued their education in a chronological manner. Tracy first attended North Carolina State University from 2001 to 2004, where they obtained their Bachelor of Science degree in Biology. Following this, they enrolled at the University of North Carolina at Chapel Hill, where they pursued a Ph.D. in Toxicology from 2005 to 2010.